We are live on ! Find out more
PC

Permanens Capital Portfolio holdings

AUM $972M
1-Year Est. Return 27.73%
This Fund
S&P 500
This Quarter Est. Return
+13.75%
1 Year Est. Return
+27.73%
3 Year Est. Return
+76.92%
5 Year Est. Return
+81.54%
10 Year Est. Return
+277.71%
AUM
$475M
AUM Growth
+$186M
Cap. Flow
+$141M
Cap. Flow %
29.61%
Top 10 Hldgs %
75.48%
Holding
133
New
14
Increased
61
Reduced
15
Closed
5

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.28%
2 Technology 5.72%
3 Healthcare 4.19%
4 Financials 4.16%
5 Consumer Discretionary 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZIXI
126
DELISTED
Zix Corporation
ZIXI
$1K ﹤0.01%
100
BIL icon
127
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$0 ﹤0.01%
1
OPLN
128
Openlane
OPLN
$4.28B
-1,760
Closed -$25K
NFLX icon
129
Netflix
NFLX
$340B
-5,200
Closed -$260K
SPLV icon
130
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
-1,601
Closed -$86K
USIG icon
131
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.5B
$0 ﹤0.01%
4
VAR
132
DELISTED
Varian Medical Systems, Inc.
VAR
-500
Closed -$86K
AMAG
133
DELISTED
AMAG Pharmaceuticals
AMAG
-359,311
Closed -$3.38M

Similar funds

Permanens Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Permanens Capital held 133 positions worth $475M, up 64% from $290M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Permanens Capital deployed $141M of net new capital in Q4 2020, opening 14 new positions and adding to 61 existing holdings. Its largest new stake was Air Products & Chemicals: 18,391 shares worth $5.03M.

By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 93% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $14.2M trimmed.

  • Permanens Capital's largest Q4 2020 buy was Air Products & Chemicals: 18,391 shares worth $5.03M.
  • Permanens Capital added most to Vanguard Morningstar Value ETF in Q4 2020, an estimated $29.4M increase.
  • Permanens Capital's biggest Q4 2020 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $14.2M.
  • Permanens Capital fully exited AMAG Pharmaceuticals in Q4 2020, selling an estimated $3.38M.
  • Permanens Capital's ten largest holdings make up 75% of its $475M portfolio in Q4 2020.
  • Permanens Capital opened 14 new positions and closed 5 in Q4 2020.
  • Permanens Capital's portfolio value rose 64% quarter-over-quarter to $475M.

Based on Permanens Capital's 13F filing for Q4 2020, filed 12 Feb 2021.